Intrathecal Gene Therapy For SLC13A5 Citrate Transporter Disorder

Clinical trial NCT07102524 · RECRUITING

Trial details

NCT number: NCT07102524
Sponsor: TESS Research Foundation
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

SLC13A5 Citrate Transporter Disorder

Start date: 2026-07-15
Primary completion: 2030-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.